Ascend Wellness Holdings (AAWH) Non Operating Income (2020 - 2026)

Ascend Wellness Holdings' (AAWH) quarterly Non Operating Income came in at -$20.1 million in Q1 2026, down 87.92% year-on-year from -$166.7 million in Q1 2025, and down 31.62% quarter-over-quarter from -$15.3 million in Q4 2025.

Ascend Wellness Holdings (AAWH) Non Operating Income (2020 - 2026) Analysis & Trends

Ascend Wellness Holdings' Non Operating Income history runs 7 years deep, the most recent figure standing at -$20.1 million for Q1 2026.

  • On a quarterly basis, Non Operating Income fell 87.92% year-over-year to -$20.1 million in Q1 2026; TTM through Mar 2026 was -$59.2 million, a 25.89% decrease from a year earlier, with the FY2025 full-year figure at -$49.8 million, down 11.78% from the prior year.
  • Non Operating Income fell to -$20.1 million in Q1 2026 per AAWH's latest filing, from -$15.3 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $13.6 million in Q2 2023 and bottomed at -$20.1 million in Q1 2026.
  • The 5-year median for Non Operating Income is -$8.7 million (2023), against an average of -$9.3 million.
  • Across the five-year window, Non Operating Income jumped 249.13% in 2023 and plunged 160.13% in 2024, its largest moves.
  • Year by year, Non Operating Income stood at -$8.5 million in 2022, then increased by 6.63% to -$7.9 million in 2023, then tumbled by 52.53% to -$12.1 million in 2024, then retreated by 26.4% to -$15.3 million in 2025, then slumped by 31.62% to -$20.1 million in 2026.
  • Per Business Quant, the three latest AAWH Non Operating Income figures stand at -$20.1 million (Q1 2026), -$15.3 million (Q4 2025), and -$12.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -216.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 20.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -7.50 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 53.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Ascend Wellness Holdings 83.00 Mn 22.91 Mn 44.88 Mn -20.13 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -20.13 Mn
Dec 31, 2025 -15.30 Mn
Sep 30, 2025 -12.22 Mn
Jun 30, 2025 -11.57 Mn
Mar 31, 2025 -10.71 Mn
Dec 31, 2024 -12.10 Mn
Sep 30, 2024 -16.07 Mn
Jun 30, 2024 -8.16 Mn
Mar 31, 2024 -8.23 Mn
Dec 31, 2023 -7.93 Mn
Sep 30, 2023 -8.06 Mn
Jun 30, 2023 13.56 Mn
Mar 31, 2023 -8.71 Mn
Dec 31, 2022 -8.50 Mn
Sep 30, 2022 -8.16 Mn
Jun 30, 2022 -9.10 Mn
Mar 31, 2022 -5.93 Mn
Dec 31, 2021 -7.34 Mn
Sep 30, 2021 -12.33 Mn
Jun 30, 2021 -36.81 Mn